The overexpression probability of STEAP2 in normal tissues was 82.5% (33/40), which was significantly higher than that in NSCLC tissues (16.7% [43/258]), and the difference was statistically significant (P < 0.01) (Fig. 2B) (Table 2). The gene discussed is STEAP2; the disease is non-small cell lung carcinoma.